THE selection of Zimbabwe as one of 10 global sites to roll out the revolutionary new HIV drug lenacapavir is a profoundly positive development, offering a significant opportunity to revitalise and sustain the country’s commendable fight against the HIV/Aids epidemic. This twice-yearly injectable drug directly addresses one of the most persistent challenges in global HIV…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions